Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SX3P
Consumer Staples
SX3P
Consumer Staples
SX3P
-0.40%
616.71
-2.50
-0.40%
—619.21618.96618.96615.58——
SX6P
Utilities
SX6P
Utilities
SX6P
+0.82%
535.23
+4.37
+0.82%
—530.86530.03535.50526.25——
SX8P
Technology
SX8P
Technology
SX8P
+0.39%
934.29
+3.67
+0.39%
—930.62924.86935.91921.75——
SXAP
Consumer Discretionary
SXAP
Consumer Discretionary
SXAP
-1.85%
447.62
-8.43
-1.85%
—456.05452.80452.80446.45——
SXDP
Health Care
SXDP
Health Care
SXDP
-0.54%
1,084.78
-5.85
-0.54%
—1,090.631,086.801,086.801,078.00——
SXEP
Energy
SXEP
Energy
SXEP
+1.47%
543.19
+7.85
+1.47%
—535.34536.16543.49536.16——
SXFP
Financials
SXFP
Financials
SXFP
-0.21%
888.33
-1.90
-0.21%
—890.23887.34889.41883.68——
SXKP
Communications
SXKP
Communications
SXKP
+0.77%
315.20
+2.42
+0.77%
—312.78311.95315.51310.80——
SXNP
Industrials
SXNP
Industrials
SXNP
-0.48%
1,090.39
-5.21
-0.48%
—1,095.601,090.801,091.601,082.31——
SXPP
Materials
SXPP
Materials
SXPP
-0.61%
813.05
-5.02
-0.61%
—818.07813.89814.53804.46——
603538:SHA
Ningbo Menovo Pharmaceutical Co Ltd
CNÂ¥50.13
-1.32%
(-0.67) 1D
May 18, 3:00:01 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 603538...
Open
CNÂ¥51.01
High
CNÂ¥52.31
Low
CNÂ¥49.80
Mkt. cap
12.33B
Avg. vol.
63.98M
Volume
29.44M
P/E ratio
100.25
52-wk high
CNÂ¥70.39
52-wk low
CNÂ¥13.93
EPS
CNÂ¥0.50
Shares outstanding
149.13M
No. of employees
2K
News stories
From sources across the web
About Ningbo Menovo Pharmaceutical Co Ltd
CEO-
Employees2.37K
FoundedFeb 19, 2004
Headquarters-
SectorPharmaceutical industry
Websitemenovopharm.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
400.85M
439.46M
386.33M
337.65M
Cost of goods sold
268.53M
290.04M
264.93M
246.07M
Cost of revenue
268.53M
290.04M
264.93M
246.07M
Research and development expenses
25.11M
24.18M
45.05M
9.59M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
61.05M
55.14M
59.07M
43.79M
Operating expense
98.33M
66.34M
122.37M
47.60M
Total operating expenses
366.86M
356.38M
387.30M
293.67M
Operating income
33.99M
83.08M
-974.95K
43.98M
Other non operating income
2.81M
-1.09M
-4.04M
-9.70M
EBT including unusual items
31.41M
57.88M
11.60M
37.14M
EBT excluding unusual items
29.27M
74.21M
-14.36M
35.96M
Income tax expense
1.52M
9.83M
6.62M
4.67M
Effective tax rate
4.83%
16.98%
57.06%
12.57%
Other operating expenses
9.09M
-13.90M
14.54M
-3.13M
Net income
27.83M
46.87M
6.30M
31.16M
Net profit margin
6.94%
10.67%
1.63%
9.23%
Earnings per share
-
-
-
-
Interest and investment income
10.17M
3.30M
-
12.36M
Interest expense
-18.64M
-10.14M
-5.68M
-10.67M
Net interest expenses
-8.47M
-6.84M
-5.68M
1.68M
Depreciation and amortization charges
-
-
-
-
EBITDA
67.33M
115.47M
32.08M
77.03M
Gain or loss from assets sale
1.90M
-1.90M
142.66K
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer